Navigation Links
Medizone International, Inc. Approves Repurchase of Global Marketing Rights
Date:12/16/2009

SAN FRANCISCO, Dec. 16 /PRNewswire-FirstCall/ -- Medizone International, Inc. (OTC Bulletin Board: MZEI) reported that its Board of Directors and the Board of Medizone New Zealand Ltd., a joint venture in which Medizone International Inc. holds a 50% interest, agreed on December 14, 2009 to unwind the joint venture and reconvey to Medizone International all global marketing rights of the company's intellectual property. Medizone International's Chairman, Edwin G. Marshall said, "Time has eroded the relevance of the joint venture we established in 1995 and the partnership no longer fits with the business plan of Medizone International moving forward. We have mutually agreed that it is in the best interest of both Medizone New Zealand Ltd., and Medizone International, Inc., to find a fair basis to terminate the marketing rights and to wind up the joint venture." The transaction should be concluded by December 31, 2009.

The parties agreed that Medizone International Inc. would pay Solwin Investments Ltd., the New Zealand principal in Medizone New Zealand Ltd. $125,000 in shares of Medizone International common stock priced at $0.40 per share, $0.015 above the closing market price on the day agreement was reached. The joint venture held licensing and marketing rights for Medizone products in Australia and its territories, New Zealand and its territories, the South Pacific Islands, the Philippines, Indonesia, Viet Nam, Cambodia, Laos, Thailand, Malaysia and Singapore. Noted Marshall, "In recapturing all marketing and licensing rights to these territories, Medizone International now retains global marketing and licensing rights for all of its future products, paving the way for implementation of its revised business plan."

Medizone International, Inc., is a research and development company engaged in developing its AsepticSure(TM) technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. Full-scale mock-up trials are scheduled to begin in January at its research laboratories located in Innovation Park, Queens University in Kingston, Ontario, Canada.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.


           Investor Relations: 415-868-0300 / web site: www.medizoneint.com
                          E-mail: operations@medizoneint.com

SOURCE Medizone International, Inc.


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medizone International, Inc. Announces OTCBB Listing
2. Medizone Expects OTCBB Listing
3. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
4. Medizone International, Inc. (MZEI.PK) Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park, Queens University at Kingston, Ontario, Canada.
5. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
6. Medizone Announces a Second Round of Trials Have Begun.
7. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
8. Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
9. AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation
10. Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
11. CEO and Founder of Project Lifesaver International, Gene Saunders, Selected to Receive Two Awards From Local Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed ... geared towards children of all ages; it is a non-competitive, non-timed event, which is ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... $3,296 in property taxes a year. In some states—like New York, New Jersey, ... By contrast, many overseas retirement havens have extremely low property-tax rates, which contributes ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: